167 related articles for article (PubMed ID: 18924132)
1. Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells.
Schmitz F; Heit A; Dreher S; Eisenächer K; Mages J; Haas T; Krug A; Janssen KP; Kirschning CJ; Wagner H
Eur J Immunol; 2008 Nov; 38(11):2981-92. PubMed ID: 18924132
[TBL] [Abstract][Full Text] [Related]
2. The TSC-mTOR signaling pathway regulates the innate inflammatory response.
Weichhart T; Costantino G; Poglitsch M; Rosner M; Zeyda M; Stuhlmeier KM; Kolbe T; Stulnig TM; Hörl WH; Hengstschläger M; Müller M; Säemann MD
Immunity; 2008 Oct; 29(4):565-77. PubMed ID: 18848473
[TBL] [Abstract][Full Text] [Related]
3. The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications.
Weichhart T; Säemann MD
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii70-4. PubMed ID: 19022819
[TBL] [Abstract][Full Text] [Related]
4. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
Bibollet-Bahena O; Almazan G
J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
[TBL] [Abstract][Full Text] [Related]
5. Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model.
Hummel M; Kurian SM; Lin S; Borodyanskiy A; Zhang Z; Li Z; Kim SJ; Salomon DR; Abecassis M
Transplantation; 2009 Jan; 87(2):178-88. PubMed ID: 19155971
[TBL] [Abstract][Full Text] [Related]
6. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress.
O'Neill LA
Immunol Rev; 2008 Dec; 226():10-8. PubMed ID: 19161412
[TBL] [Abstract][Full Text] [Related]
7. The multiple facets of mTOR in immunity.
Weichhart T; Säemann MD
Trends Immunol; 2009 May; 30(5):218-26. PubMed ID: 19362054
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic effect of proliferation signal inhibitors: from biology to clinical application.
Bertoni E; Salvadori M
J Nephrol; 2009; 22(4):457-62. PubMed ID: 19662600
[TBL] [Abstract][Full Text] [Related]
9. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes.
Kopp A; Buechler C; Neumeier M; Weigert J; Aslanidis C; Schölmerich J; Schäffler A
Obesity (Silver Spring); 2009 Apr; 17(4):648-56. PubMed ID: 19148127
[TBL] [Abstract][Full Text] [Related]
10. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin.
Lee JK; Kim SY; Kim YS; Lee WH; Hwang DH; Lee JY
Biochem Pharmacol; 2009 Apr; 77(8):1391-400. PubMed ID: 19426678
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease.
Brereton CF; Sutton CE; Lalor SJ; Lavelle EC; Mills KH
J Immunol; 2009 Aug; 183(3):1715-23. PubMed ID: 19570828
[TBL] [Abstract][Full Text] [Related]
12. The role of mTOR in the management of solid tumors: an overview.
Strimpakos AS; Karapanagiotou EM; Saif MW; Syrigos KN
Cancer Treat Rev; 2009 Apr; 35(2):148-59. PubMed ID: 19013721
[TBL] [Abstract][Full Text] [Related]
13. Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori.
Rad R; Ballhorn W; Voland P; Eisenächer K; Mages J; Rad L; Ferstl R; Lang R; Wagner H; Schmid RM; Bauer S; Prinz C; Kirschning CJ; Krug A
Gastroenterology; 2009 Jun; 136(7):2247-57. PubMed ID: 19272387
[TBL] [Abstract][Full Text] [Related]
14. Ribavirin enhances interferon signaling via stimulation of mTOR and p53 activities.
Su WC; Liu WL; Cheng CW; Chou YB; Hung KH; Huang WH; Wu CL; Li YT; Shiau AL; Lai MY
FEBS Lett; 2009 Sep; 583(17):2793-8. PubMed ID: 19619545
[TBL] [Abstract][Full Text] [Related]
15. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands.
de Vos AF; Pater JM; van den Pangaart PS; de Kruif MD; van 't Veer C; van der Poll T
J Immunol; 2009 Jul; 183(1):533-42. PubMed ID: 19542464
[TBL] [Abstract][Full Text] [Related]
16. A putative mitotic checkpoint dependent on mTOR function controls cell proliferation and survival in ovarian granulosa cells.
Yaba A; Bianchi V; Borini A; Johnson J
Reprod Sci; 2008 Feb; 15(2):128-38. PubMed ID: 18276949
[TBL] [Abstract][Full Text] [Related]
17. Growth suppressive cytokines and the AKT/mTOR pathway.
Kroczynska B; Kaur S; Platanias LC
Cytokine; 2009; 48(1-2):138-43. PubMed ID: 19682919
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.
Ronellenfitsch MW; Brucker DP; Burger MC; Wolking S; Tritschler F; Rieger J; Wick W; Weller M; Steinbach JP
Brain; 2009 Jun; 132(Pt 6):1509-22. PubMed ID: 19416948
[TBL] [Abstract][Full Text] [Related]
19. The role of mTOR in the adaptation and failure of beta-cells in type 2 diabetes.
Leibowitz G; Cerasi E; Ketzinel-Gilad M
Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():157-69. PubMed ID: 18834443
[TBL] [Abstract][Full Text] [Related]
20. Psychological stress suppresses innate IFN-gamma production via glucocorticoid receptor activation: reversal by the anxiolytic chlordiazepoxide.
Curtin NM; Boyle NT; Mills KH; Connor TJ
Brain Behav Immun; 2009 May; 23(4):535-47. PubMed ID: 19217938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
